BIAGINI, AGNESE Statistiche
BIAGINI, AGNESE
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
2017-01-01 Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Il carcinoma della tiroide
2017-01-01 Molinaro, Eleonora; Biagini, Agnese; Matrone, Antonio; Vitti, Paolo
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience
2016-01-01 Viola, David; Valerio, Laura; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Lorusso, Loredana; Cappagli, Virginia; Pieruzzi, Letizia; Giani, Carlotta; Sabini, Elena; Passannati, Paolo; Puleo, Luciana; Matrone, Antonio; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE
2014-01-01 Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience
2014-01-01 Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
2014-01-01 Elisei, Rossella; Agate, Laura; Viola, David; Matrone, A; Biagini, Agnese; Molinaro, Eleonora
Il carcinoma tiroideo: nuove prospettive terapeutiche.
2014-01-01 Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC)
2014-01-01 Matrone, A.; Gambale, C.; Molinaro, E.; Agate, L.; Bottici, V.; Biagini, A.; Viola, D.; Vitti, P.; Elisei, R.
Ret Oncogene and Thyroid Carcinoma
2014-01-01 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Biagini, Agnese; Matrone, Antonio; Tacito, Alessia; Ciampi, Raffaele; Vivaldi, Agnese; Romei, Cristina
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC)
2014-01-01 Gambale, Carla; Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Viola, David; Mazzeo, Salvatore; Bianchi, Francesca; Brozzi, Federica; Vitti, Paolo; Elisei, Rossella
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico.
2013-01-01 Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F.; Brozzi, F.; Viola, David; Ceccarelli, C.; Elisei, Rossella
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
2013-01-01 Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study
2012-01-01 Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study.
2011-01-01 Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2011-01-01 Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
. Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio.
2010-01-01 Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor.
2010-01-01 Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy
2009-01-01 Miccoli, Paolo; Pinchera, Aldo; Materazzi, Gabriele; Biagini, Agnese; Berti, Piero; Faviana, Pinuccia; Molinaro, Eleonora; Viola, David; Elisei, Rossella
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study
2008-01-01 Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
2007-01-01 Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies | 1-gen-2017 | Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
| Il carcinoma della tiroide | 1-gen-2017 | Molinaro, Eleonora; Biagini, Agnese; Matrone, Antonio; Vitti, Paolo | |
| Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience | 1-gen-2016 | Viola, David; Valerio, Laura; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Lorusso, Loredana; Cappagli, Virginia; Pieruzzi, Letizia; Giani, Carlotta; Sabini, Elena; Passannati, Paolo; Puleo, Luciana; Matrone, Antonio; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella | |
| CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE | 1-gen-2014 | Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina | |
| Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience | 1-gen-2014 | Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina | |
| How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level. | 1-gen-2014 | Elisei, Rossella; Agate, Laura; Viola, David; Matrone, A; Biagini, Agnese; Molinaro, Eleonora | |
| Il carcinoma tiroideo: nuove prospettive terapeutiche. | 1-gen-2014 | Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella | |
| Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) | 1-gen-2014 | Matrone, A.; Gambale, C.; Molinaro, E.; Agate, L.; Bottici, V.; Biagini, A.; Viola, D.; Vitti, P.; Elisei, R. | |
| Ret Oncogene and Thyroid Carcinoma | 1-gen-2014 | Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Biagini, Agnese; Matrone, Antonio; Tacito, Alessia; Ciampi, Raffaele; Vivaldi, Agnese; Romei, Cristina | |
| The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) | 1-gen-2014 | Gambale, Carla; Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Viola, David; Mazzeo, Salvatore; Bianchi, Francesca; Brozzi, Federica; Vitti, Paolo; Elisei, Rossella | |
| Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. | 1-gen-2013 | Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F.; Brozzi, F.; Viola, David; Ceccarelli, C.; Elisei, Rossella | |
| Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. | 1-gen-2013 | Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella | |
| The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study | 1-gen-2012 | Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio | |
| Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. | 1-gen-2011 | Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella | |
| RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) | 1-gen-2011 | Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| . Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio. | 1-gen-2010 | Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella | |
| Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. | 1-gen-2010 | Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella | |
| Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy | 1-gen-2009 | Miccoli, Paolo; Pinchera, Aldo; Materazzi, Gabriele; Biagini, Agnese; Berti, Piero; Faviana, Pinuccia; Molinaro, Eleonora; Viola, David; Elisei, Rossella | |
| BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study | 1-gen-2008 | Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio | |
| BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. | 1-gen-2007 | Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella |